PH12013500143A1 - A method of treating alzheimer`s disease - Google Patents

A method of treating alzheimer`s disease

Info

Publication number
PH12013500143A1
PH12013500143A1 PH1/2013/500143A PH12013500143A PH12013500143A1 PH 12013500143 A1 PH12013500143 A1 PH 12013500143A1 PH 12013500143 A PH12013500143 A PH 12013500143A PH 12013500143 A1 PH12013500143 A1 PH 12013500143A1
Authority
PH
Philippines
Prior art keywords
disease
treating alzheimer
antibodies
activated
potentiated form
Prior art date
Application number
PH1/2013/500143A
Other languages
English (en)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44863153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12013500143(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130353/15A external-priority patent/RU2542445C2/ru
Priority claimed from RU2011127058/15A external-priority patent/RU2536232C2/ru
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of PH12013500143A1 publication Critical patent/PH12013500143A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH1/2013/500143A 2010-07-21 2011-07-15 A method of treating alzheimer`s disease PH12013500143A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2010130353/15A RU2542445C2 (ru) 2010-07-21 2010-07-21 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
RU2011127058/15A RU2536232C2 (ru) 2011-07-01 2011-07-01 Лекарственное средство для лечения болезни альцгеймера и способ лечения болезни альцгеймера
PCT/IB2011/002434 WO2012010978A2 (en) 2010-07-21 2011-07-15 A method of treating alzheimer's disease

Publications (1)

Publication Number Publication Date
PH12013500143A1 true PH12013500143A1 (en) 2019-09-02

Family

ID=44863153

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/500143A PH12013500143A1 (en) 2010-07-21 2011-07-15 A method of treating alzheimer`s disease

Country Status (16)

Country Link
US (1) US20130058982A1 (enExample)
EP (1) EP2596021A2 (enExample)
JP (1) JP2013535445A (enExample)
CN (1) CN103119060A (enExample)
AU (1) AU2011281252A1 (enExample)
CA (1) CA2805943A1 (enExample)
DE (1) DE112011102409T5 (enExample)
EA (1) EA029399B1 (enExample)
FR (1) FR2962912A1 (enExample)
GB (1) GB2496801B (enExample)
IT (1) ITTO20110633A1 (enExample)
MX (1) MX2013000808A (enExample)
NZ (1) NZ606969A (enExample)
PH (1) PH12013500143A1 (enExample)
UA (1) UA107836C2 (enExample)
WO (1) WO2012010978A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
DE112011102349T5 (de) 2010-07-15 2013-04-18 Oleg Iliich Epshtein Pharmazeutische Zusammensetzung und Behandlungsverfahren
CZ2013105A3 (cs) * 2010-07-15 2013-05-22 Iliich Epshtein@Oleg Zpusob zvýsení úcinku aktivované potencované formy protilátky
WO2012010970A2 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
BR112013001296A2 (pt) * 2010-07-21 2017-12-19 Lliich Epshtein Oleg composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
CN104324359B (zh) * 2014-09-25 2016-08-17 中山大学 Rry三肽在制备治疗阿尔茨海默症药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2156621C1 (ru) 1999-03-04 2000-09-27 Эпштейн Олег Ильич Нейротропное лекарственное средство
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
AU2002258518A1 (en) * 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
US6451547B1 (en) * 2001-04-25 2002-09-17 Syn X Pharma Process for differential diagnosis of Alzheimer's dementia and device therefor
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
JP2006516089A (ja) * 2002-10-02 2006-06-22 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
TWI345470B (en) 2003-03-14 2011-07-21 Nutrition Res Inc Homeopathic formulations useful for treating pain and/or inflammation
BRPI0601496B8 (pt) * 2006-04-13 2021-05-25 Miria De Amorim composições medicamentosas, uso das mesmas, kits medicamentosos e método de aplicação das composições medicamentosas
BR112013001296A2 (pt) * 2010-07-21 2017-12-19 Lliich Epshtein Oleg composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa

Also Published As

Publication number Publication date
CN103119060A (zh) 2013-05-22
DE112011102409T5 (de) 2013-07-04
AU2011281252A1 (en) 2013-03-07
NZ606969A (en) 2015-08-28
GB201302929D0 (en) 2013-04-03
EA029399B1 (ru) 2018-03-30
WO2012010978A3 (en) 2012-04-26
GB2496801A (en) 2013-05-22
GB2496801B (en) 2018-04-11
EA201300130A1 (ru) 2013-12-30
EP2596021A2 (en) 2013-05-29
UA107836C2 (uk) 2015-02-25
ITTO20110633A1 (it) 2012-01-22
CA2805943A1 (en) 2012-01-26
MX2013000808A (es) 2013-10-28
JP2013535445A (ja) 2013-09-12
WO2012010978A2 (en) 2012-01-26
FR2962912A1 (fr) 2012-01-27
US20130058982A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
PH12013500143A1 (en) A method of treating alzheimer`s disease
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
MY159398A (en) Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
WO2012019168A3 (en) Engineered nucleic acids and methods of use thereof
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
PH12012501830A1 (en) Bispecific, bivalent anti-vegf/anti-ang-2 antibodies
UA118332C2 (uk) Білок, що зв'язує антиген cd27l
MY178142A (en) Anti-phf-tau antibodies and their uses
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
EP4406612A8 (en) Anti-cd70 antibody drug conjugates
MX342034B (es) Proteinas monovalentes que se unen a antigenos.
PH12013501636A1 (en) Treatment of osteoarthritis and pain
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
NZ606988A (en) Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
GB2496337A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
PH12013500933A1 (en) Methods and compositions for neural disease immunotherapy
WO2012014078A3 (en) Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy
MX2015006859A (es) Anticuerpos anti-vegf y sus usos.
FR2955253B1 (fr) Procede cosmetique de modification de l'apparence du contour de l'oeil.
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
NZ606970A (en) A method of treating attention deficit hyperactivity disorder
WO2012165900A3 (ko) 골 형성 또는 혈관신생 촉진용 펩타이드 ｂｆｐ 4 및 이의 용도
WO2014033158A3 (en) Pcsk9 peptide vaccine